Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption.
Mehdizadeh
Morteza
M
Department of Ophthalmology, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Nowroozzadeh
Mohammad Hosein
MH
D000284:Administration, Oral; D000328:Adult; D002386:Cataract / Q000139:chemically induced / Q000503:physiopathology; D000077543:Deferiprone; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007903:Lens Capsule, Crystalline / Q000503:physiopathology* / Q000601:surgery; D019654:Lens Implantation, Intraocular; D008297:Male; D018918:Phacoemulsification; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects*; D015354:Vision, Low / Q000139:chemically induced; D014792:Visual Acuity; D017086:beta-Thalassemia / Q000188:drug therapy*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone